Description
Leukaemia stem cells are thought to be the source of relapse following treatment with conventional therapies. New and emerging treatments are better at targeting the core programs that are turned on in the cancer stem cells, however it is still unclear what that core program is and how to increase the effectiveness of current treatments in disabling the leukaemia stem cell program. This project will aim to discover new strategies to eradicate leukaemia stem cells by restoring normal blood gene expression programs.
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
Cancer stem cells, gene regulation, therapies
School
School of Translational Medicine » Australian Centre for Blood Diseases (ACBD)
Available options
PhD/Doctorate
Masters by research
Honours
Time commitment
Full-time
Top-up scholarship funding available
Yes
Year 1:
$5000
Physical location
Australian Centre for Blood Diseases